Feasibility of routine clinical liquid‐based cytology for lung cancer compact panel testing
Yoshiki Shinomiya, Kanako C. Hatanaka, Asami Okumura, Ayae Nange, Mamiko Yamamoto, Manabu Azuma, Katsuji Marukawa, Yuko Ishida, Tomohiro Shimizu, Ryoko Watanabe, Yamato Hashimoto, Mitsuharu Abiko, Yoshiharu Sato, Jun Sakakibara‐Konishi, Tatsuya Kato, Shinya Tanaka, Yutaka HatanakaAbstract
Background
The Lung Cancer Compact Panel (cPANEL) is a recently approved highly sensitive multiplex gene panel in Japan that supports both DNA‐ and RNA‐based next‐generation sequencing. Although cytological specimens are acceptable for cPANEL, unfixed cell pellets or dedicated preservation tubes are typically recommended. However, evidence remains limited regarding whether residual liquid‐based cytology (LBC) cell suspensions prepared for routine cytological diagnosis can be used directly for cPANEL testing without dedicated molecular preservation or additional preanalytical processing. In this study, we evaluated the feasibility of applying LBC specimens that are widely used in contemporary clinical practice to cPANEL.
Methods
We analyzed DNA and RNA quality in 69 clinical LBC specimens. Among these, 51 specimens containing non‐small cell lung cancer cells with previously determined driver alteration status were subjected to cPANEL testing to evaluate assay concordance with clinical companion diagnostic results.
Results
DNA integrity was generally well preserved (DNA Integrity Number [DIN]: 6.2 ± 1.5). In contrast, RNA integrity showed greater variability (DV200: 16.4 ± 12.1%). ThinPrep‐fixed specimens demonstrated lower DIN and DV200 values compared with CytoRich Red‐fixed specimens. Although all samples successfully passed the DNA‐based cPANEL assay, six cases (11.8%) failed the RNA‐based assay, with RNA yield being a major contributing factor. Among the 46 evaluable specimens, concordance was 95.7% and sensitivity was 92.3%, or 88.9% including RNA module failures as cPANEL‐negative.
Conclusions
With appropriate fixative selection and adequate cellularity, cPANEL using clinical LBC specimens may serve as a practical diagnostic platform. We demonstrated that routine LBC specimens can be directly applied to cPANEL without special preanalytical processing.